This blog is related to the various litigations related to patents w.r.t pharma industry.
Tuesday, November 17, 2009
GAVI Alliance manages to lower cost of pentavalent vaccines to US$ 3 per dose
The Geneva-based public-private partnership, GAVI Alliance, has managed to bring down the price of the pentavalent vaccines by 50 cents and it now costs US$ 3 per dose effective from 2010.
No comments:
Post a Comment